Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare system
Objectives: Standard molecular testing for patients with stage IV non-small cell lung cancer (NSCLC) in the Canadian publicly funded health system includes single gene testing for EGFR, ALK, and ROS-1. Comprehensive genomic profiling (CGP) may broaden treatment options for patients. This study exami...
Main Authors: | Kirstin Perdrizet, Tracy L. Stockley, Jennifer H. Law, Adam Smith, Tong Zhang, Roxanne Fernandes, Muqdas Shabir, Peter Sabatini, Nadia Al Youssef, Christine Ishu, Janice JN Li, Ming-Sound Tsao, Prodipto Pal, Michael Cabanero, Joerg Schwock, Hyang Mi Ko, Scott Boerner, Heather Ruff, Frances A. Shepherd, Penelope A. Bradbury, Geoffrey Liu, Adrian G. Sacher, Natasha B. Leighl |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Cancer Treatment and Research Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468294222000259 |
Similar Items
-
The effect of prior cancer on non‐small cell lung cancer trial eligibility
by: Michael Herman, et al.
Published: (2021-07-01) -
Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer
by: Shelley Kuang, et al.
Published: (2022-06-01) -
The Evolving Role of Immunotherapy in Stage III Non-Small Cell Lung Cancer
by: Kirstin Perdrizet, et al.
Published: (2021-12-01) -
Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer—A Cost-Efficient Strategy in a Public Healthcare System
by: Maisam Makarem, et al.
Published: (2021-08-01) -
Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies
by: Sally C.M. Lau, MD, MPH, et al.
Published: (2023-10-01)